Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Graefes Arch Clin Exp Ophthalmol ; 259(8): 2441-2450, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-33704563

RESUMEN

PURPOSE: To evaluate the safety, efficacy, and patient satisfaction with a pharmacological treatment of presbyopia performed with the Benozzi's method. METHODS: A non-randomized multicentric case-series retrospective study was developed. Were included patients from 5 centers of Argentina, from January 2010 to June 2019, aged at baseline between 40 and 60 years old, with binocular uncorrected distance visual acuity (UDVA) of 25/20 or better, and with uncorrected near visual acuity (UNVA) at least Jaeger (J) 2 or worse. The treatment was performed with a patented formulation (pilocarpine and diclofenac preservative-free eye drops). The main outcome was binocular UNVA and UDVA. Differences were evaluated by paired t-test. The presence of side effects and patient's satisfaction were also evaluated. Data was analyzed in separated groups according to their follow-up time, from 2 to 10 years. RESULTS: A total of 148 patients were included. At baseline, the UNVA for the different groups were between J3 and J8 which was improved to J1 to J2. The mean baseline UDVA has been ranged between 0.02 and 0.04 logMAR. The mean baseline UDVA has been ranged between 0.02 to 0.04 logMAR, after treatment were between 0.01 to 0.03, without a statisticallysignificant improvement. Side effects were spontaneously resolved, and subjective evaluation shows that patients were satisfied. CONCLUSIONS: This first multicentric shows that Benozzi's method for presbyopia treatment was safety and improves the UNVA without affecting the UDVA, maintaining their efficacy even after 10 years, in a population aged between 40 and 60 years old, from different ophthalmic centers in Argentina.


Asunto(s)
Presbiopía , Adulto , Humanos , Persona de Mediana Edad , Satisfacción del Paciente , Presbiopía/tratamiento farmacológico , Refracción Ocular , Estudios Retrospectivos , Resultado del Tratamiento , Visión Binocular , Agudeza Visual
2.
Endocrinol Diabetes Nutr ; 64 Suppl 1: 7-14, 2017 Mar.
Artículo en Inglés, Español | MEDLINE | ID: mdl-28440763

RESUMEN

OBJECTIVE: To provide recommendations based on evidence on the management of vitaminD deficiency in the general population. PARTICIPANTS: Members of the Bone Metabolism Working Group of the Spanish Society of Endocrinology. METHODS: Recommendations were formulated using the GRADE system (Grading of Recommendations, Assessment, Development, and Evaluation) to describe both the strength of recommendations and the quality of evidence. A systematic search was made in MEDLINE (Pubmed) using the term VitaminD and the name of each issue. Papers in English and Spanish with publication date before 17 March 2016 were included. Recommendations were jointly discussed by the Working Group. CONCLUSIONS: This document summarizes the data about vitaminD deficiency in terms of prevalence, etiology, screening indications, adequate levels and effects of supplementation on bone and non-skeletal health outcomes.


Asunto(s)
Vitamina D , Accidentes por Caídas/prevención & control , Anciano , Enfermedades Óseas/complicaciones , Suplementos Dietéticos , Medicina Basada en la Evidencia , Femenino , Fracturas Óseas/prevención & control , Humanos , Enfermedades Renales/complicaciones , Hepatopatías/complicaciones , Síndromes de Malabsorción/complicaciones , Masculino , Metaanálisis como Asunto , Persona de Mediana Edad , Debilidad Muscular/etiología , Debilidad Muscular/prevención & control , Necesidades Nutricionales , Obesidad/complicaciones , Osteoporosis/prevención & control , Factores de Riesgo , Vitamina D/análogos & derivados , Vitamina D/sangre , Deficiencia de Vitamina D/etiología , Deficiencia de Vitamina D/prevención & control , Deficiencia de Vitamina D/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA